Update on pathomechanisms and treatments in allergic rhinitis

Y Zhang, F Lan, L Zhang - Allergy, 2022 - Wiley Online Library
Allergic rhinitis (AR) is a global health problem with increasing prevalence and association
with an enormous medical and socioeconomic burden. New recognition of immune cells …

Mechanistic and therapeutic approaches to occupational exposure-associated allergic and non-allergic asthmatic disease

AD Schwab, JA Poole - Current allergy and asthma reports, 2023 - Springer
Abstract Purpose of Review Occupational lung disease, including asthma, is a significant
cause of disability worldwide. The dose, exposure frequency, and nature of the causal agent …

[HTML][HTML] Efficacy and safety of stapokibart (CM310) in uncontrolled seasonal allergic rhinitis (MERAK): an investigator-initiated, placebo-controlled, randomised …

Y Zhang, B Yan, Z Zhu, X Wang, X Song, D Zhu… - …, 2024 - thelancet.com
Background There is no trial to assess the benefits of periodically using biologics during the
pollen season in patients with uncontrolled seasonal allergic rhinitis (SAR), who have …

B lineage cells and IgE in allergic rhinitis and CRSwNP and the role of omalizumab treatment

J Bai, BK Tan - American Journal of Rhinology & Allergy, 2023 - journals.sagepub.com
Background Allergic rhinitis (AR) and chronic rhinosinusitis (CRS) are two prevalent nasal
diseases where both type 2 inflammation and immunoglobulin E (IgE) may play important …

Comparison of clinical traits for seasonal and perennial allergic rhinitis during allergen exposure

K Wang, Y Zhang, L Wan, J Li, C Wang… - Allergy and Asthma …, 2024 - ingentaconnect.com
Background: Allergic rhinitis (AR) is traditionally subdivided into seasonal AR (SAR) and
perennial AR (PAR) according to the type of allergen and the occurrence of symptoms …

[HTML][HTML] Blood and local eosinophil levels in chronic rhinitis: Observations during seasonal allergen exposure and non-exposure

X Xu, J Li, X Zhang, L Xi, Y Gao, X Li, Y Zhang… - World Allergy …, 2024 - Elsevier
Background Allergic rhinitis (AR) is a typical type 2 inflammatory disease and eosinophils
play a critical role of cardinal effectors in type 2 inflammation. However, the distribution of …

[PDF][PDF] 变应性鼻炎非特异性免疫治疗的研究进展

韩东园, 徐博怀, 余璐洁, 裘奇阳, 何勇 - 新医学, 2022 - xinyixue.cn
变应性鼻炎(AR) 是耳鼻咽喉科的一种常见病, 多发病, 由于病程迁延, 易反复发作,
不仅会影响患者身心健康和生活质量, 还会加重社会医疗卫生负担. 尽管目前临床上AR …

Prevention of omalizumab for seasonal allergic rhinoconjunctivitis: a retrospective cohort study

R Tang, S Lei, L Zhu, Y Lv, H Li - Frontiers in Immunology, 2022 - frontiersin.org
Background Allergic rhinoconjunctivitis (ARC) is an allergic disease that is characterized by
conjunctival and nasal symptoms such as edema and congestion of conjunctiva, rhinorrhea …

Efficacy and safety of a proposed omalizumab biosimilar compared to the reference product in the management of uncontrolled moderate-to-severe allergic asthma: a …

M Ghanei, B Ghalebaghi, R Sami… - Frontiers in …, 2024 - frontiersin.org
Background and aims Allergic asthma has a considerable burden on the quality of life. A
significant portion of moderate-to-severe allergic asthma patients need omalizumab, an anti …

Main Airborne Pollen Species and Characteristics of Allergic Rhinitis Patients with Pollen-Related Allergies in 13 Northern Chinese Cities

J Zhang, Y Yan, F Jiang, J Chen… - Journal of Asthma and …, 2024 - Taylor & Francis
Background Pollen allergies have a high prevalence in northern China, whereas, the types
of pollen allergens and population characteristics among different regions remain unclear …